Under construction – not a live service
Sign in
WithdrawnNo phase

Augmented Reality-based Telerehabilitation Platform for Patients With Stroke

Reason given: Study did not receive funding

Key facts

Where
Stanford, United StatesSee the site

Where in United States

  • Stanford UniversityStanford, United StatesNo longer taking part

Trial details

Who runs it
Stanford University
Trial code
NCT06963645
Record updated
27 April 2026
Original description
The study is to 1) determine the feasibility of the use of our augmented reality (AR) rehabilitation program, including its preliminary efficacy, 2) determine the feasibility of obtaining an augmented reality assessment based on the Fugl-Meyer Assessment - Upper Extremity (FMA-UE).Read full original descriptionShow less

Augmented Reality-based Telerehabilitation Platform for Patients With Stroke: A Feasibility Study

The study is to 1) determine the feasibility of the use of our augmented reality (AR) rehabilitation program, including its preliminary efficacy, 2) determine the feasibility of obtaining an augmented reality assessment based on the Fugl-Meyer Assessment - Upper Extremity (FMA-UE).

Inclusion: 18 years or older; ≥3 months post ischemic or hemorrhagic stroke; Upper extremity deficit with an FMA-UE score between 20-50; Able to operate the AR device independently or with the help of a caregiver; Sufficiently proficient in the English language to follow instructions from Reia.

Exclusion: History of developmental, neurological or psychological impairment leading to functional disability; Vision or visual field impairment that interferes with the use of the AR headset; History of visually provoked seizures; Cardiac pacemaker; Severe photosensitivity that makes use of the AR headset uncomfortable; Hearing aids; Implantable cardioverter-defibrillator (ICD).

ClinicalTrials.gov NCT06963645